Orthopedics is concerned with the correction or prevention of deformities and impaired functions of the muscular-skeletal system. Pathological abnormalities can be congenital in nature or be the consequence of disease and/or trauma.
Traumatology and orthopedics are interconnected: mechanical, physical, and chemical damage causes local and general changes in the body.
Orthopedic diseases are classified by their nature/localization into:
Until now, orthopedic treatment has involved non-operative (conservative) therapy and surgery.
Regenerative medicine is a fundamentally new form of therapy for the treatment of degenerative joints, muscles, and ligaments based on autologous mesenchymal stem cell (MSC) therapy.
The course of therapy provides a symptomatic improvement within a few weeks and months. This innovative technology offers the opportunity to preserve joints, postpone their prosthetics, and improve quality of life.
Make an appointment!Benefits
Mesenchymal stem cells have the capacity of forming bones, cartilages, connective tissue, and adipose tissue. The goal of the therapy is a complete regeneration of damaged tissues which can be a worthy innovative alternative to invasive orthopedic treatments.
In addition, cell therapy is used to reduce inflammation, disease severity, and cure autoimmune rheumatic diseases.
Sampling is performed as follows:
There are a few routes of the administration of autologous MSCs depending on the type of the disease; this is individual to each patient. The simultaneous combination of two routes of administration is possible:
Examination, carrying out laboratory tests, a conclusion about the nature and severity of the disease, calculating the preparation dose required for administration/frequency of administration.
Doctor’s appointment, verifying the correctness of the primary diagnosis based on the clinical tests results. Booking the MSCs extraction date. The pre-operative anesthesia consultation.
MSCs sampling: you may need to stay in the observation word approximately up to two hours. During that time, the MSCs, having been isolated, are already cultivated in the SmartCell laboratory.
On the appointed day, the preparation is administered; it can take about 60 min.
60-120 min after the procedure, the patient can return to normal life. During some period of time, the patient is under the individual dynamic medical supervision.
Before, or during MSC therapy, AMC therapy is performed as an obligatory stage of regenerative treatment. This is an individual program based on the application of autologous growth factors and oligopeptides isolated from the patient’s platelets at a maximum concentration. AMC therapy helps to activate a number of regenerative processes: an inflow of stem cells, their active transformation into the required tissues, the growth of blood vessels, accelerated cell regeneration.
The first improvements can be observed already within the first week after the autologous MSCs administration. 1-1.5 months after the procedure, the therapeutic results in the treatment of a particular neurodegenerative disease become even more evident.
© 2023 — Биотехнологическая компания "SmartCell" Продвижение сайта - Inweb.
